Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 42
Filter
Add more filters










Publication year range
1.
Prog Drug Res ; 57: 77-115, 2001.
Article in English | MEDLINE | ID: mdl-11728003

ABSTRACT

Viral quasispecies dynamics and variations of viral fitness are reviewed in connection with viral disease control. Emphasis is put on resistance of human immunodeficiency virus and some human DNA viruses to antiviral inhibitors. Future trends in multiple target antiviral therapy and new approaches based on virus entry into error catastrophe (extinction mutagenesis) are discussed.


Subject(s)
Anti-HIV Agents/therapeutic use , HIV Infections/prevention & control , HIV/genetics , Virus Diseases/prevention & control , DNA Viruses/drug effects , DNA Viruses/genetics , Drug Resistance, Viral/genetics , HIV Infections/drug therapy , Hepatitis B, Chronic/drug therapy , Hepatitis B, Chronic/prevention & control , Humans , Influenza, Human/drug therapy , Influenza, Human/prevention & control , Mutagenesis , RNA Viruses/drug effects , RNA Viruses/genetics , Virus Diseases/drug therapy
2.
Biochemistry (Mosc) ; 66(9): 999-1007, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11703183

ABSTRACT

The interaction of dNTPs with the active site of HIV-1 reverse transcriptase (HIV RT) has been investigated. The kinetic parameters of primer elongation catalyzed by wild-type HIV-1 RT and two of its mutants with substitutions for Tyr115 using dTTP and two of its photoreactive analogs were determined. The substitution for Tyr115 with alanine or tryptophan resulted in an increase in K(m) values of dTTP and its analogs. Wild-type RT and its mutants were photoaffinity modified using photoreactive primer synthesized in situ. The modification was made in two variants: direct photocross-linking under UV irradiation and photosensitized modification using Pyr-dUTP as a sensitizer. The use of the sensitizer decreased the number of modification products and increased selective labeling of the catalytic subunit of both the mutant and wild-type RT.


Subject(s)
Deoxyuracil Nucleotides/chemistry , Deoxyuracil Nucleotides/metabolism , HIV Reverse Transcriptase/chemistry , HIV Reverse Transcriptase/metabolism , Photoaffinity Labels/chemistry , Alanine/genetics , Alanine/metabolism , Amino Acid Substitution , Binding Sites , Catalytic Domain , Dideoxynucleotides , HIV Reverse Transcriptase/genetics , Kinetics , Magnesium/metabolism , Manganese/metabolism , Photochemistry/methods , Tryptophan/genetics , Tryptophan/metabolism , Tyrosine/genetics , Tyrosine/metabolism , Ultraviolet Rays , Uracil Nucleotides/chemistry , Uracil Nucleotides/metabolism
5.
J Biol Chem ; 276(29): 27470-9, 2001 Jul 20.
Article in English | MEDLINE | ID: mdl-11353775

ABSTRACT

Human immunodeficiency virus (HIV)-1 strains have been divided into three groups: main (M), outlier (O), and non-M non-O (N). Biochemical analyses of HIV-1 reverse transcriptase (RT) have been performed predominantly with enzymes derived from HIV-1 group M:subtype B laboratory strains. This study was designed to optimize the expression and to characterize the enzymatic properties of HIV-1 group O RTs as well as chimeric RTs composed of group M and O p66 and p51 subunits. The DNA-dependent DNA polymerase activity on a short heteropolymeric template-primer was similar with all enzymes, i.e. the HIV-1 group O and M and chimeric RTs. Our data revealed that the 51-kDa subunit in the chimeric heterodimer p66(M:B)/p51(O) confers increased heterodimer stability and partial resistance to non-nucleoside RT inhibitors. Chimeric RTs (p66(M:B)/p51(O) and p66(O)/p51(M:B)) were unable to initiate reverse transcription from tRNA(3)(Lys) using HIV-1 group O or group M:subtype B RNA templates. In contrast, HIV-1 group O and M RTs supported (-)-strand DNA synthesis from tRNA(3)(Lys) hybridized to any of their corresponding HIV-1 RNA templates. HIV-2 RT could not initiate reverse transcription on tRNA(3)(Lys)-primed HIV-1 genomic RNA. These findings suggest that the initiation event is conserved between HIV-1 groups, but not HIV types.


Subject(s)
HIV Reverse Transcriptase/metabolism , Recombinant Fusion Proteins/metabolism , Base Sequence , DNA Primers , HIV Reverse Transcriptase/chemistry , HIV Reverse Transcriptase/isolation & purification , HIV-1/genetics , HIV-2/genetics , Humans , Models, Molecular , Molecular Sequence Data , Nucleic Acid Conformation , Protein Conformation , RNA, Viral/chemistry , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/isolation & purification , Reverse Transcriptase Inhibitors/pharmacology , Sequence Homology, Nucleic Acid
6.
Nucleic Acids Res ; 29(24): 4963-72, 2001 Dec 15.
Article in English | MEDLINE | ID: mdl-11812826

ABSTRACT

A compensatory mutation (M230I) in the primer grip of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) restores the replication capacity of virus having a Y115W mutation in their RT coding region. The Y115W substitution impairs DNA polymerase activity and produces an enzyme with a lower fidelity of DNA synthesis. Gel-based fidelity assays with the double mutant Y115W/M230I revealed that the M230I substitution increased the accuracy of mutant Y115W. Y115W/M230I showed wild-type misinsertion fidelity in assays performed with DNA/DNA templates. However, when present alone, M230I conferred reduced fidelity as determined in misinsertion and mispair extension fidelity assays, as well as in primer extension assays carried out with three dNTPs. The mutant M230I showed a 3.3-16-fold increase in misinsertion efficiency for G, C and T opposite T, compared with the wild-type enzyme. Its fidelity was not influenced by nucleotide substitutions in the template/primer around the incorporation site. However, its accuracy was apparently affected by the structure of the 5'-overhang of the template strand. Unlike wild-type HIV-1 RT, nucleotide selectivity of mutant M230I at dT:dG, dT:dC and dT:dT mispairs was almost exclusively dependent on the K(m) values for correct and incorrect dNTPs, a characteristic that has not been described for other low fidelity mutants of HIV-1 RT.


Subject(s)
DNA Replication/genetics , HIV Reverse Transcriptase/genetics , HIV-1/genetics , DNA Primers/chemistry , DNA Primers/genetics , DNA, Viral/chemistry , DNA, Viral/genetics , HIV-1/enzymology , Humans , Mutation , Nucleic Acid Conformation , Suppression, Genetic , Templates, Genetic
7.
EMBO J ; 19(21): 5752-61, 2000 Nov 01.
Article in English | MEDLINE | ID: mdl-11060026

ABSTRACT

The 3'-azido-3'-deoxythymidine (AZT)-resistant pheno type of a heavily mutated human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) carrying a dipeptide (Ser-Ser) insertion between codons 69 and 70 as well as other mutations related to resistance to RT inhibitors has been studied. Recombinant virus carrying this variant RT (termed SS RT) showed reduced susceptibility to all nucleoside RT inhibitors in clinical use, particularly to AZT. In the presence of ATP, recombinant SS RT had an increased ability to remove the 3'-terminal nucleotide from AZT- terminated primers and extend the unblocked primer, compared with wild-type HIV-1 RT (BH10 isolate). Insertion of two serines in the sequence context of BH10 RT did not affect the ATP-dependent phosphorolytic activity of the enzyme, and had no influence in resistance to RT inhibitors. However, SS RT mutants lacking the dipeptide insertion or bearing a four-serine insertion showed reduced ATP-dependent phosphorolytic activity that correlated with increased AZT sensitivity, as determined using a recombinant virus assay. Therefore, the insertion appears to be critical to enhance AZT resistance in the sequence context of multidrug-resistant HIV-1 RT.


Subject(s)
HIV Reverse Transcriptase/chemistry , HIV Reverse Transcriptase/genetics , Reverse Transcriptase Inhibitors/pharmacology , Zidovudine/pharmacology , Amino Acid Sequence , Base Sequence , Codon/genetics , DNA Primers/genetics , Drug Resistance, Microbial/genetics , Genetic Variation , HIV Reverse Transcriptase/metabolism , HIV-1/enzymology , HIV-1/genetics , HIV-1/isolation & purification , Humans , Kinetics , Molecular Sequence Data , Mutation , Phenotype
8.
J Biol Chem ; 275(26): 19759-67, 2000 Jun 30.
Article in English | MEDLINE | ID: mdl-10748215

ABSTRACT

The catalytic efficiency of incorporation of deoxyribonucleotides by wild-type human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) was around 100-fold higher than for dideoxyribonucleotides, in Mg(2+)-catalyzed reactions, and more than 10,000-fold higher than for nucleotides having a 2'-hydroxyl group in Mg(2+)- and Mn(2+)-catalyzed reactions. Mutant RTs with nonconservative substitutions affecting Tyr-115 (Y115V, Y115A, and Y115G) showed a dramatic reduction in their ability to discriminate against ribonucleotides in the presence of both cations. However, selectivity of deoxyribonucleotides versus ribonucleotides was not affected in mutants Y115W and F160W. The substitution of Tyr-115 with Val or Gly had no effect on discrimination against dideoxyribonucleotides, but these mutants were less efficient than the wild-type RT in discriminating against cordycepin 5'-triphosphate. We also show that Tyr-115 is involved in fidelity of DNA synthesis, but substitutions at this position have different effects depending on the metal cofactor used in the assays. In Mg(2+)-catalyzed reactions, removal of the side chain of Tyr-115 reduced misinsertion and mispair extension fidelity, while opposite effects were observed in Mn(2+)-catalyzed reactions. Our results indicate that the aromatic side chain of Tyr-115 plays a role as a "steric gate" preventing the incorporation of nucleotides with a 2'-hydroxyl group in a cation-independent manner, while its influence on fidelity could be modulated by Mg(2+) or Mn(2+).


Subject(s)
DNA/biosynthesis , HIV Reverse Transcriptase/genetics , HIV Reverse Transcriptase/metabolism , Ribose/physiology , Tyrosine/physiology , Amino Acid Sequence , Binding Sites , DNA Polymerase I/chemistry , DNA Polymerase III/chemistry , Dinucleoside Phosphates/metabolism , HIV Reverse Transcriptase/chemistry , Kinetics , Magnesium/metabolism , Manganese/metabolism , Models, Molecular , Molecular Sequence Data , Mutagenesis , RNA-Directed DNA Polymerase/chemistry , Ribonucleotides/metabolism , Sequence Homology, Amino Acid
9.
Virus Res ; 66(1): 13-26, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10653914

ABSTRACT

A small proportion (0.8%) of individuals of a cohort of HIV-1 infected patients subjected to prolonged therapy with nucleoside analogues included a recently recognised dipeptide insertion in their RT (Ser-Ser or Ser-Gly between RT codons 69 and 70). To study the dynamics of dominance of genomes with this genetic change, sequential HIV-1 isolates from two patients were analyzed with regard to consensus sequences and complexity of mutant spectra. The two patients displayed completely different, complex evolutionary patterns leading to temporary dominance of dipeptide insertions. In one patient, a virus very closely related to an ancestor virus from the same patient overtook the population at late times, displacing genomes encoding a Ser-Ser insertion. In another patient the sequential dominance of genomes with Ser-Ser insertion-->no insertion-->Ser-Gly insertion was observed. These three types of genomes coexisted in the mutant spectrum of one HIV-1 isolate. Complexity was also reflected in the shape of phylogenetic trees derived with genomes from the mutant spectrum at each time point. The results suggest that HIV-1 genomes encoding a dipeptide insertion between RT codons 69 and 70 do not show a clear selective advantage over other genomes lacking the insertion. Such an absence of a clear selective advantage will favor that such genomes encoding this RT insertion become dominant only in a transient fashion, and following disparate kinetics in different patients.


Subject(s)
Anti-HIV Agents/therapeutic use , HIV Infections/drug therapy , HIV Reverse Transcriptase/genetics , HIV-1/drug effects , Mutagenesis, Insertional , Adult , Amino Acid Substitution , Anti-HIV Agents/pharmacology , DNA, Viral/analysis , Dipeptides/genetics , Drug Resistance, Microbial/genetics , Evolution, Molecular , HIV Infections/virology , HIV Protease/genetics , HIV-1/classification , HIV-1/genetics , Humans , Male , Molecular Sequence Data , Phylogeny , Proviruses , Reverse Transcriptase Inhibitors/pharmacology , Reverse Transcriptase Inhibitors/therapeutic use , Sequence Analysis, DNA
10.
Virus Genes ; 18(3): 203-10, 1999.
Article in English | MEDLINE | ID: mdl-10456788

ABSTRACT

We report a statistical analysis of genetic heterogeneity of the reverse transcriptase (RT)-coding region of human immunodeficiency virus type 1. Both newly determined sequences and sequences contained in the data banks have been examined. For the calculations, the viral samples and the regions within the RT molecule were divided in two groups. The viral samples were split into those from patients not subjected to antiretroviral therapy and those from patients treated with zidovudine (AZT, 3'-azido-3'-deoxythymidine) alone or in combination with other RT inhibitors. The RT-coding region was divided into segments encoding beta-strands and segments encoding alpha-helices. A significantly lower heterogeneity was observed in beta-strands relative to the alpha-helix coding segments. Application of the D test of Tajima has provided evidence of operation of negative (or purifying) selection in sequences from viruses of patients not subjected to antiretroviral treatment as well as in treated patients. In the group of untreated individuals, regions encoding beta-strands are subjected to stronger negative selection than those encoding alpha-helices. It is likely that the observed differences reflect stronger functional constraints in beta-strands than in alpha-helices of RT.


Subject(s)
HIV Infections/drug therapy , HIV Reverse Transcriptase/chemistry , Polymorphism, Genetic , Zidovudine/therapeutic use , Adolescent , Adult , Amino Acid Sequence , Anti-HIV Agents/therapeutic use , Base Sequence , Child , DNA Primers , DNA-Directed DNA Polymerase/chemistry , Female , Humans , Male , Middle Aged , Molecular Sequence Data , Reverse Transcriptase Inhibitors/therapeutic use , Sequence Homology, Amino Acid
11.
J Mol Biol ; 290(3): 615-25, 1999 Jul 16.
Article in English | MEDLINE | ID: mdl-10395818

ABSTRACT

The highly conserved Phe160 residue is located in the "palm" subdomain of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT), and makes contact with Tyr115, a residue which is involved in deoxynucleoside triphosphate (dNTP) binding and fidelity of DNA synthesis. Five mutant RTs having Tyr, Trp, Ile, Ala or Gln instead of Phe160 were obtained by site-directed mutagenesis. F160Y and F160W retained substantial DNA polymerase activity, whereas the catalytic efficiency of nucleotide incorporation of mutants F160I, F160A and F160Q was less than 10 % that of the wild-type RT, using poly(rA).oligo(dT)20 as the template-primer. The low catalytic efficiency of mutants F160I, F160A and F160Q was due to their lower affinity for the dNTP substrate. F160Y displayed similar kinetic parameters as the wild-type RT in nucleotide insertion assays carried out with heteropolymeric DNA/DNA template-primers. However, nucleotide affinity was two- to sixfold reduced in the case of mutant F160W. Fidelity assays revealed similar misinsertion and mispair extension ratios for the three enzymes, although F160W showed a slightly higher accuracy of DNA synthesis, particularly in the presence of high concentrations of dNTP. When introduced in an infectious proviral clone, mutations F160I, F160A and F160Q rendered non-viable virus. The importance of Phe160 for polymerase function and viral replication could be mediated by its interaction with Tyr115, as suggested by the analysis of the available crystal structures of HIV-1 RT.


Subject(s)
HIV Reverse Transcriptase/metabolism , Phenylalanine/metabolism , Amino Acid Substitution , Base Sequence , Crystallography, X-Ray , DNA , HIV Reverse Transcriptase/chemistry , HIV Reverse Transcriptase/genetics , HIV-1/enzymology , HIV-1/genetics , HIV-1/physiology , Models, Molecular , Mutagenesis, Site-Directed , Phenylalanine/chemistry , Protein Conformation , Recombination, Genetic , Virus Replication
12.
J Virol ; 73(8): 6293-8, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10400720

ABSTRACT

Nonconservative substitutions for Tyr-115 in the reverse transcriptase (RT) of human immunodeficiency virus type 1 (HIV-1) lead to enzymes displaying lower affinity for deoxynucleoside triphosphates (dNTPs) (A. M. Martín-Hernández, E. Domingo, and L. Menéndez-Arias, EMBO J. 15:4434-4442, 1996). Several mutations at this position (Y115W, Y115L, Y115A, and Y115D) were introduced in an infectious HIV-1 clone, and the replicative capacity of the mutant viruses was monitored. Y115W was the only mutant able to replicate in MT-4 cells, albeit very poorly. Nucleotide sequence analysis of the progeny virus recovered from supernatants of four independent transfection experiments showed that the Y115W mutation was maintained. However, in all cases an additional substitution in the primer grip of the RT (M230I) emerged when the virus increased its replication capacity. Using recombinant HIV-1 RT, we demonstrate that M230I mitigates the polymerase activity defect of the Y115W mutant, by increasing the dNTP binding affinity of the enzyme. The second-site suppressor effects observed were mediated by mutations in the 66-kDa subunit of the RT, as demonstrated with chimeric heterodimers. Examination of available crystal structures of HIV-1 RT suggests a possible mechanism for restoration of enzyme activity by the second-site revertant.


Subject(s)
HIV Reverse Transcriptase/genetics , HIV Reverse Transcriptase/physiology , HIV-1/enzymology , Isoleucine/physiology , Methionine/physiology , Mutagenesis, Site-Directed , Tryptophan/physiology , Tyrosine/physiology , Virus Replication , Animals , COS Cells , HIV-1/physiology , Humans , Isoleucine/genetics , Methionine/genetics , Tryptophan/genetics , Tumor Cells, Cultured , Tyrosine/genetics
13.
Biochemistry ; 37(47): 16636-44, 1998 Nov 24.
Article in English | MEDLINE | ID: mdl-9843431

ABSTRACT

The role of alpha-helix E' of the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) in template-primer binding and fidelity of DNA synthesis was investigated by using a series of mutant enzymes with deletions of 4, 8, 12, 16, and 20 amino acids at the C-terminal end of the 66 kDa subunit. The dissociation equilibrium constants (Kd) of wild-type HIV-1 RT and 38/16mer and 47/25mer DNA/DNA template-primer complexes were 2.2 +/- 0.7 and 0.69 +/- 0.35 nM, respectively. Deletions involving partial or total removal of alpha-helix E' rendered enzymes with a 2-5-fold decrease in binding affinity. Misinsertion and mispair extension fidelity of DNA synthesis of the wild-type enzyme and truncated mutants were determined by using both DNA/DNA template-primers and a 47/25mer RNA/DNA complex. In all cases, incorporation assays were done in the same sequence context, which was taken from the viral gag gene. The removal of alpha-helix E' had little effect on fidelity as determined with the three template-primers. Misinsertion fidelity assays showed that the specificity of mismatch formation was A:C approximately A:G > A:A for the DNA template and A:C > A:G approximately A:A for the RNA template, in 47/25mers. The specificity of extending mispaired 3'-termini was similar with both 47/25mers: A:C > A:A approximately A:G. However, the efficiency of transversion mispair extension was higher with RNA templates. The results reported in this paper suggest that alpha-helix E' may stabilize the RT/template-primer interaction, but does not have a strong influence in the correct positioning of the template-primer at the polymerase active site.


Subject(s)
DNA Primers/metabolism , DNA, Viral/biosynthesis , HIV Reverse Transcriptase/genetics , Mutagenesis, Site-Directed , Base Pair Mismatch/genetics , Crystallography, X-Ray , DNA Primers/genetics , DNA, Viral/genetics , DNA-Directed DNA Polymerase/metabolism , Deoxyribonucleotides/chemistry , Deoxyribonucleotides/metabolism , HIV Reverse Transcriptase/chemistry , HIV Reverse Transcriptase/metabolism , Humans , Kinetics , Peptide Fragments/chemistry , Peptide Fragments/genetics , Peptide Fragments/metabolism , Protein Structure, Secondary , RNA, Viral/metabolism , Templates, Genetic
14.
Viral Immunol ; 11(4): 167-81, 1998.
Article in English | MEDLINE | ID: mdl-10189185

ABSTRACT

Cytotoxic T lymphocytes (CTL) play an important role in the control of human immunodeficiency virus (HIV) infection. CTL responses have been demonstrated for most of the HIV gene products, predominantly gag, pol, and env-encoded proteins, and also for the regulatory proteins Nef, Tat, Vif, or Rev. The HIV-1 reverse transcriptase (RT), which derives from expression of the pol gene, is an important target of cellular immune responses in infected individuals. More than 40 different peptides containing RT-specific CTL epitopes have been identified. The most conserved and frequently detected are located in the 'fingers' and 'palm' subdomains of the enzyme, but other epitopes have been found in the 'thumb' and 'connection' subdomains as well as in the RNase H domain. Studies on the sequence variability and functional role of amino acids forming CTL epitopes are relevant for addressing important questions relative to viral escape from immmune control and the future design of anti-AIDS vaccines.


Subject(s)
HIV Infections/immunology , HIV Reverse Transcriptase/immunology , T-Lymphocytes, Cytotoxic/immunology , AIDS Vaccines , Amino Acid Sequence , Animals , Drug Design , Epitopes, T-Lymphocyte/immunology , HIV Reverse Transcriptase/genetics , Humans , Molecular Sequence Data , Mutation , Viral Proteins/immunology
15.
Virology ; 236(2): 364-73, 1997 Sep 29.
Article in English | MEDLINE | ID: mdl-9325244

ABSTRACT

The catalytic properties and sensitivity to different inhibitors have been determined for the reverse transcriptase (RT) of group O human immunodeficiency virus type 1 (HIV-1). The RT-coding region was cloned from a new HIV-1 group O isolate from Spain, expressed in Escherichia coli, and purified by affinity chromatography. This new RT showed 79% amino acid sequence identity with the corresponding enzyme of group M subtype B strain BH10. The two enzymes showed very similar kinetics of RNA-dependent DNA polymerization using homopolymeric template-primers and RNase H specific activity. Inhibitor sensitivity to ddTTP and 3'-azido-2',3'-dideoxythymidine triphosphate (AZTTP) was also similar for both enzymes. However, the two enzymes differed dramatically in their sensitivity to several inhibitors. While the RT of the BH10 isolate was sensitive to nevirapine and loviride (IC50 ranged from 0.16 to 8.2 microM, depending on the substrates used), the enzyme of the Spanish HIV-1 group O isolate showed high-level resistance to those compounds (IC50 > 200 microM). The amino acid sequence of the RT of group O HIV-1 contains three amino acids (Cys-181, Glu-179, and Gly-98), which are found in group M subtype B strains resistant to nonnucleoside RT inhibitors. The recombinant group O HIV-1 RT should be useful for studies aimed at discovering and designing drugs directed toward group O isolates of HIV-1.


Subject(s)
HIV Reverse Transcriptase/metabolism , HIV-1/classification , HIV-1/enzymology , Adult , Amino Acid Sequence , Anti-HIV Agents/pharmacology , Base Sequence , Catalysis , Cloning, Molecular , DNA Primers/genetics , DNA, Viral/genetics , Escherichia coli/genetics , HIV Infections/virology , HIV Reverse Transcriptase/antagonists & inhibitors , HIV Reverse Transcriptase/genetics , HIV-1/genetics , Humans , Kinetics , Male , Molecular Sequence Data , Phylogeny , Polymerase Chain Reaction , Reverse Transcriptase Inhibitors/pharmacology , Sequence Homology, Amino Acid , Spain
16.
Rev Med Virol ; 7(2): 87-96, 1997 Jul.
Article in English | MEDLINE | ID: mdl-10398474

ABSTRACT

RNA viruses constitute the most abundant group of pathogens of man, animals and plants. They share high mutation rates which are in the range 10(-3) to 10(-5) misincorporations per nucleotide site and round of copying. This is due to the absence or low efficiency of proofreading-repair or postreplicative repair activities associated with replicating RNA. Populations of RNA viruses are extremely heterogeneous and form dynamic mutant swarms termed viral quasispecies. This genetic organisation implies that any individual mutant has only a fleeting existence; that is, RNA viral genomes are statistically defined but individually indeterminate. RNA viruses are able to accommodate their average nucleotide sequences to changes in environment. A parameter used to quantitate adaptation is fitness, or the relative ability of a virus to produce infectious progeny. Repeated transfers of one or a few particles (bottleneck events) generally lead to fitness losses. In contrast, large population passages allow competitive optimisation of mutant genomes and fitness gains. Of relevance to medical practice is the ability of viral quasispecies to overcome selective pressures imposed by vaccines and antiviral agents. Particularly dramatic have been the systematic isolations of HIV-1 mutants resistant to antiretroviral inhibitors in treated individuals. In addition to the ability of HIV-1 quasispecies to generate many mutant genomes in short times, calculations of mutation frequencies in the pol gene of HIV-1 populations have documented that mutations related to resistance to antiretroviral inhibitors preexist in the mutant swarms of HIV-1 quasispecies. It is not possible at present to anticipate whether a suitable drug cocktail may be capable of sustained inhibition of HIV-1 replication without selection of mutants resistant to the combination of antiviral agents. Copyright 1997 John Wiley & Sons, Ltd.

17.
Nucleic Acids Res ; 25(7): 1383-9, 1997 Apr 01.
Article in English | MEDLINE | ID: mdl-9060433

ABSTRACT

The role of Tyr115 of human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) in the mispair extension fidelity of DNA dependent DNA synthesis was analysed by using a series of 15 mutant enzymes with substitutions at Tyr115. Their kinetic parameters for elongation using homopolymeric RNA-DNA and heteropolymeric DNA-DNA complexes showed major effects of the amino acid substitutions on the Km value for dNTP. Enzymes with large hydrophobic residues at position 115 displayed lower Km values than enzymes with small and charged amino acids at this position. The influence of all these amino acid replacements in mispair extension fidelity assays was analyzed using three different mismatches (A:C, A:G and A:A) at the 3'-terminal position of the primer DNA. For the A:C mispair, a 2. 6-33.4-fold increase in mispair extension efficiency (fext) was observed as compared with the wild-type enzyme. Unexpectedly, all the mutants tested as well as the wild-type RT were very efficient in extending the A:G and A:A transversion mispairs. This effect was due to the template-primer sequence context and not to the buffer conditions of the assay. The data support a role of Tyr115 in accommodating the complementary nucleotide into the nascent DNA while polymerization takes place.


Subject(s)
DNA Replication , HIV Reverse Transcriptase/metabolism , Nucleic Acid Heteroduplexes/metabolism , Tyrosine/genetics , DNA Repair , HIV Reverse Transcriptase/chemistry , Kinetics , Mutagenesis, Site-Directed , Ribonuclease H/metabolism , Structure-Activity Relationship , Thymine Nucleotides/metabolism
19.
EMBO J ; 15(16): 4434-42, 1996 Aug 15.
Article in English | MEDLINE | ID: mdl-8861970

ABSTRACT

Tyr115 is located in the vicinity of the polymerase catalytic site of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. Site-directed mutagenesis was used to generate variant enzymes having Phe, Trp, Ala, Ser, Asp or Lys instead of Tyr115. The substitution of Tyr115 by Phe renders a fully active polymerase, displaying similar kinetic parameters, processivity and misinsertion fidelity of DNA synthesis as the wild-type enzyme. In contrast, the replacement of Tyr by Asp or Lys produced enzymes with a very low polymerase activity. The activity of the variant enzymes having Trp, Ala or Ser instead of Tyr115 was reduced significantly, particularly when poly(rA)484 was used as template. This effect was caused by a dramatic increase in the Km value for dTTP, and was detected using a DNA template mimicking a proviral HIV-1 gag sequence. Misinsertion fidelity assays revealed that mutants Y115W, Y115A and Y115S had a higher misinsertion efficiency than the wild-type reverse transcriptase. The low fidelity of these mutants appears to be related to nucleotide recognition rather than altered DNA-DNA template-primer interactions. The effects observed on the steady state kinetic constants, processivity and fidelity were mediated by the 66 kDa subunit, as demonstrated using chimeric heterodimers with the Y115A substitution in either p66 or p51.


Subject(s)
DNA Replication , HIV Reverse Transcriptase/metabolism , HIV-1/enzymology , Oligodeoxyribonucleotides/metabolism , Tyrosine/chemistry , HIV Reverse Transcriptase/chemistry , HIV Reverse Transcriptase/genetics , HIV-1/genetics , Humans , Kinetics , Mutagenesis , Mutagenesis, Site-Directed , Recombinant Fusion Proteins/metabolism , Structure-Activity Relationship , Templates, Genetic
20.
J Biol Chem ; 270(49): 29162-8, 1995 Dec 08.
Article in English | MEDLINE | ID: mdl-7493942

ABSTRACT

The differences in substrate specificity between Moloney murine leukemia virus protease (MuLV PR) and human immunodeficiency virus (HIV) PR were investigated by site-directed mutagenesis. Various amino acids, which are predicted to form the substrate binding site of MuLV PR, were replaced by the equivalent ones in HIV-1 and HIV-2 PRs. The expressed mutants were assayed with the substrate Val-Ser-Gln-Asn-Tyr decreases Pro-Ile-Val-Gln-NH2 (decreases indicates the cleavage site) and a series of analogs containing single amino acid substitutions in positions P4(Ser) to P3'(Val). Mutations at the predicted S2/S2' subsites of MuLV PR have a strong influence on the substrate specificity of this enzyme, as observed with mutants H37D, V39I, V54I, A57I, and L92I. On the other hand, substitutions at the flap region of MuLV PR often rendered enzymes with low activity (e.g. W53I/Q55G). Three amino acids (His-37, Val-39, and Ala-57) were identified as the major determinants of the differences in substrate specificity between MuLV and HIV PRs.


Subject(s)
Endopeptidases/chemistry , HIV Protease/chemistry , Leukemia Virus, Murine/enzymology , Viral Proteins/chemistry , Amino Acid Sequence , Base Sequence , Binding Sites , HIV Protease/metabolism , Molecular Sequence Data , Mutagenesis, Site-Directed , Structure-Activity Relationship , Substrate Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...